Federal · 119th Congress
Biosimilars Access and Affordability Act
Policy areaHealth
The Congressional Research Service has not published a summary of this measure.
Read the text of the bill →Sponsor
Cosponsors3
Other titles2
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.Official Title as Introduced
Biosimilars Access and Affordability ActShort Title(s) as Introduced
Legislative history1
Sep 28, 2026
SenateRead twice and referred to the Committee on Finance.